Surge testing is to start in Manchester where a new Covid-19 variant has been found.
According to BBC North West, the testing will focus mainly in South Manchester where four cases of the Kent variant have found in two unconnected households.
The surge testing will begin tomorrow (Tues 9 Feb) in specific postcode areas (M14 4, M14 7, M15 5, M15 6, M16 7 and M16 8) with more than 10,000 tests set to be supplied to the community.
Additional testing sites will be set up in the area to enable everyone over the age of 16 who live, works, or studies in in the designated area to get a test as quickly as possible.
Surge testing is to start in Manchester where a new Covid-19 variant has been found. It focuses mainly in South Manchester in these postcode areas M14 4, M14 7, M15 5, M15 6, M16 7 and M16 8. pic.twitter.com/oKrRFDg6rc
In the coming days, volunteers will also begin knocking on people’s doors to offer alternative testing for anyone who can’t get out to a testing site, and testing will also be made available for people who work but don’t necessarily live in the area.
ADVERTISEMENT
David Regan, Director of Public Health, Manchester City Council, said: “We all know that the virus will change over time and it’s important that we investigate new strains to understand how they might spread. This is exactly what we’re doing with the intensive testing in parts of Manchester with local testing units and people going door-to-door to offer people tests.
“There is no evidence that this variant will be resistant to the vaccines or causes a more severe illness, and it is not yet known if the strain can be passed more easily between people. But it is really important that everyone who lives in the boundary area and is over the age of 16 plays their part and gets a test.
ADVERTISEMENT
“The best thing we can all do it to keep following the rules – Hands, Face, Space – get a test if you have symptoms, and keep your vaccination appointment when you are called.”
Cllr Bev Craig, Manchester City Council’s executive member for adult health and well-being, said: “It’s understandable that some residents in the area may be concerned by all this, but we need to remember that it’s very normal for viruses to mutate. The important thing is that this mutation has been identified and that we’re taking action to stop its spread.
“We are following the public health approach to react to the new variant and we will be working with community groups, local champions, MPs and councillors to ensure as many people as possible know how to get a test so we can understand more about this version of the virus.
ADVERTISEMENT
“There are no changes to the restrictions in Manchester and if you do have to go out for one of the permitted reasons, please make sure you carry on following the rules on social distancing, and wearing a face covering, as well as washing your hands regularly.”
If you live in any of the aforementioned post code areas, please check the Council’s website.
News
New endometriosis pill helping hundreds of women with ‘debilitating’ condition to be made available on NHS
Emily Sergeant
A groundbreaking new pill to help women with a ‘debilitating’ condition is set to be made available on the NHS.
The new daily pill for endometriosis – which has been approved for use on the NHS in England by the National Institute for Health and Care Excellence (NICE) – is called linzagolix, and will be available for those who have had previous treatment for endometriosis, working to manage any symptoms they may be experiencing.
Around 1.5 million women in the UK are thought to be currently living with endometriosis.
Endometriosis can cause chronic pain, heavy periods, and extreme tiredness when tissue similar to the womb lining grows elsewhere in the body.
A new daily pill for endometriosis has been approved for use on the NHS, and could help over a thousand women in England every year manage the symptoms of the debilitating condition.
As mentioned, linzagolix will be available specifically for patients whose previous medical or surgical treatments for endometriosis have been unsuccessful, and will be given alongside ‘add-back’ hormone therapy – which involves using low-dose hormone replacement therapy (HRT) to prevent menopause-like symptoms and bone loss.
This is the second take-at-home treatment to be approved to treat endometriosis on the NHS, and it’s thought that more than 1,000 women will benefit.
In clinical trials, linzagolix was shown to be successful in reducing painful periods and non-menstrual pelvic pain, compared with placebo, hence why it has been approved on the NHS by NICE.
“This is welcome news for women with endometriosis who haven’t found relief from previous therapies or surgery,” commented Dr Sue Mann, who is the National Clinical Director in Women’s Health for NHS England.
“It’s another treatment option which will help women take control of their health and better manage the symptoms of this often painful and debilitating condition.
“This is a testament to our ongoing commitment to improving treatment, care and quality of life for women.”
Featured Image – Heute
News
Wigan woman jailed after hitting pedestrian in Fiat 500 while driving high on nitrous oxide ‘balloons’
Emily Sergeant
A young woman from Wigan has been handed jail time after hitting a pedestrian while driving high on nitrous oxide.
Louisa Tunstall was driving a white Fiat 500 towards the East Lancashire Road in Wigan at around 7pm on Friday 24 May 2024 – a time when traffic conditions were said to be ‘quiet’ – but Tunstall was under the influence of a now-banned drug, nitrous oxide, at the time of the incident, Greater Manchester Police (GMP) confirmed.
While driving under the influence, 19-year-old Tunstall veered to the left onto the pavement and collided with a 51-year-old woman pedestrian.
After striking the woman, the car then overturned and, in the process, caused serious life-changing injuries.
When questioned by police, Tunstall stated that she ‘took her eyes off the road’ to retrieve something in the footwell before knowing the car had flipped, but she also confirmed that she had just been out to purchase nitrous oxide to use that evening.
After obtaining witness accounts, investigating officers were able to track down nearby CCTV footable which showed Tunstall inhaling nitrous oxide through a balloon whilst driving, seconds before the collision occurred.
#JAILED | It's not a laughing matter when you get behind the wheel under the influence of drugs.
Now Louisa Tunstall has to spend over a year behind bars after inhaling nitrous oxide and causing serious injury in #Wigan last year.
— Greater Manchester Police (@gmpolice) May 14, 2025
Further investigation by GMP’s Forensic Vehicle Examination Unit examined the Fiat 500 and confirmed that no defects were found on the car to contribute towards the collision.
Still to this day, the victim says she is trying to recover from the injuries sustained to her leg that will prevent her from continuing life as she did before.
“The incident is still very raw when I think about it,” the victim explained in her impact statement released by GMP. “I become upset when I think at everything which has been taken away from me and the ongoing affect it has had and continues to have on my daily life.”
GMP says it’s seeing the use of nitrous oxide being a factor in incidents they attend increasing year on year.
Nitrous oxide, also known as ‘laughing gas’, is reported to produce euphoria, relaxation, dizziness, giggling or laughing fits, impaired judgement, and occasionally dissociation and hallucinations – which GMP says affects reaction time and and is ‘likely lead to impairment’ in driving performance, particularly when faced with an unexpected or hazardous situation.
Tunstall appeared at Bolton Crown Court this week, and has been sentenced to one year and eight months imprisonment for having possession of a Class C drug, driving under the influence of drugs, and causing serious injury by dangerous driving.
Alongside being jailed, she was also disqualified from driving for two years and eight months, and has been ordered to take an extended test when she is released.